Drug Profile
ME 1209
Alternative Names: CP 6679Latest Information Update: 29 Nov 2006
Price :
$50
*
At a glance
- Originator Meiji Seika Kaisha
- Class Antibacterials; Cephalosporins
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 29 Nov 2006 Discontinued - Preclinical for Bacterial infections in Japan (Parenteral)
- 08 Jun 2001 Preclinical development for Bacterial infections in Japan (Parenteral)
- 04 Aug 1998 No-Development-Reported for Bacterial infections in Japan (Parenteral)